Can lupus nephritis affect my sister’s fertility at 35?

Hello,

Welcome to icliniq.com.

I have read your query and can understand your concern.

What she is going through sounds incredibly difficult and heartbreaking, both physically and emotionally. Lupus nephritis Class IV, or diffuse proliferative lupus nephritis, is the most severe form of kidney involvement in systemic lupus erythematosus (SLE). Unfortunately, it often requires aggressive immunosuppressive treatment to try to preserve kidney function.

However, the side effects of these treatments, particularly Cyclophosphamide (an alkylating agent) and Prednisone (a corticosteroid), can be devastating. It sounds like your sister is experiencing many of the most serious complications.

Menstrual cessation and fertility concerns:

The loss of her menstrual periods (amenorrhea) after Cyclophosphamide is a known and serious complication. Cyclophosphamide is toxic to the ovaries, especially at higher cumulative doses or in women over the age of 30. This ovarian toxicity can lead to premature ovarian failure and potentially permanent infertility.

Whether her periods will return depends on several factors:

• The total dose of Cyclophosphamide she received.

• Her baseline ovarian reserve.

• Her age (at 35 years, the ovaries are already more vulnerable).

• Whether gonadal protection was used during treatment, such as with Gonadotropin-releasing hormone (GnRH) agonists like Leuprolide (Lupron).

If ovarian protection was not provided, there is unfortunately a higher risk that the amenorrhea may be permanent. However, some women do resume menstruation several months after Cyclophosphamide is discontinued, once the body has had time to recover.

Hormonal testing can help assess her ovarian function. These include:

• Follicle-Stimulating Hormone (FSH).

• Luteinizing Hormone (LH).

• Estradiol.

• Anti-Müllerian Hormone (AMH).

Fertility and future pregnancy safety: In terms of future pregnancy, it is not safe to conceive during an active lupus flare or when kidney function is declining. With her serum creatinine of 2.1 milligrams per deciliter, nephrotic-range proteinuria (4 and above on dipstick), uncontrolled hypertension, and elevated anti-double-stranded DNA (anti-dsDNA) antibodies, her lupus is considered highly active.

Pregnancy under these conditions is very risky and increases the chance of:

• Miscarriage.

• Preeclampsia.

• Preterm delivery.

• Further kidney damage.

If dialysis becomes necessary, those risks increase even more.

That said, if her disease can be brought under control, defined as at least six months of clinical remission with:

• Stable kidney function.

• Significantly reduced proteinuria.

• Controlled blood pressure.

• Normalized or near-normal laboratory markers.

Then pregnancy could be considered in the future, but only under specialized high-risk obstetric care, ideally involving both a rheumatologist and a maternal-fetal medicine (MFM) specialist.

Treatment resistance and alternative options.

Although Mycophenolate Mofetil (an antimetabolite immunosuppressant) is effective for many patients with lupus nephritis, not all individuals respond. The combination of rising creatinine, persistent heavy proteinuria, and complications like avascular necrosis (AVN) suggests that her disease may be refractory and aggressive.

In cases like this, other options may include:

• Rituximab (a B-cell depleting monoclonal antibody).

• Belimumab (a B-lymphocyte stimulator inhibitor).

• Participation in clinical trials for new lupus therapies.

Plasmapheresis or dialysis may be needed as supportive interventions, but they do not treat the underlying autoimmune activity, only the consequences.

Blood pressure management:

Her blood pressure of 165/95 mmHg, despite taking Lisinopril (an angiotensin-converting enzyme inhibitor), indicates suboptimal control. In lupus nephritis, tight blood pressure control is critical to preserve kidney function. A second antihypertensive agent, such as a calcium channel blocker or diuretic, may be necessary.

Recommended next steps:

1. Hormonal evaluation: Request testing for FSH, LH, Estradiol, and AMH to assess ovarian reserve.

2. Blood pressure optimization: Reevaluate her antihypertensive regimen to achieve the target blood pressure.

3. Fertility counseling: Discuss options for fertility preservation, such as egg retrieval if ovarian function remains.

4. Multidisciplinary care: Ensure coordination between a nephrologist, rheumatologist, and high-risk obstetrician.

5. Emotional support: Consider psychotherapy or counseling to support her emotional well-being, which is critical during such a challenging time.

I hope this helps.

Thank you.